Latest news
Claris Bio unveils development strategy - The Pharma LetterThe Pharma Letter · Tue, 28 Jul 2026 07:00:00 GMTClaris Bio Unveils Development Strategy, Planned Pivotal Study Supported by $118 Million Series B Financing from Top-Tier Investors, and Multiple Leadership Appointments - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMTAn eye drug biotech banks $118M and stocks its executive suite - BioPharma DiveBioPharma Dive · Tue, 28 Jul 2026 07:00:00 GMT